Skip to main content

Cutaneous Sarcoidosis Outcome Instruments: Reliability and Validity Among Dermatologists, Pulmonologists, and Rheumatologists

  • Living reference work entry
  • First Online:
Cutaneous Biometrics
  • 143 Accesses

Abstract

Valid and reliable cutaneous sarcoidosis outcome instruments are required for the rigorous clinical research that will lead to evidence-based treatments for cutaneous sarcoidosis. Cutaneous sarcoidosis outcome instruments may provide an accessible, low-cost, low-risk tool to measure disease activity and should be accessible and comprehensible to non-dermatologist investigators. The sarcoidosis activity and severity index (SASI) and the cutaneous sarcoidosis activity and morphology instrument (CSAMI) both demonstrate validity and reliability among dermatologists and non-dermatologists alike. The CSAMI correlates strongly with patient-reported quality of life (QOL) metrics, as well as histologic measures of disease activity. The SASI is a simpler tool initially developed for the assessment of facial sarcoidosis, which has been successfully utilized as an outcome instrument in clinical trials. Both of these instruments demonstrated markedly decreased reliability when tested using store-and-forward teledermatology technology. High-frequency ultrasonography (HFU) is an emerging technology that could provide a valid, reliable, and objective measure of cutaneous sarcoidosis activity. Further research is needed to establish standardized imaging protocols and confirm the results of existing studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Baughman RP, Judson MA, Teirstein A, Lower EE, Lo K, Schlenker-Herceg R, Barnathan ES. Chronic facial sarcoidosis including lupus pernio. Am J Clin Dermatol. 2008;9(3):155–61.

    Article  Google Scholar 

  • Baughman RP, Judson MA, Ingledue R, Craft NL, Lower EE. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis. Arch Dermatol. 2012;148(2):262–4.

    Article  CAS  Google Scholar 

  • Berg SA, Yeung H, English JC, Keimig EL, Kim EJ, Micheletti RG, Wanat KA, Judson MA, Baughman RP, Rosenbach M. Inter-rater reliability of cutaneous sarcoidosis assessment tools via remote photographic assessment. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33(3):315–29.

    Google Scholar 

  • Drake WP, Oswald-Richter K, Richmond BW, Ison J, Burke VE, Algood H, Braun N, Taylor T, Pandit KV, Aboud C, Yu C, Kaminski N, Boyd AS, King LE. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis a randomized, single-masked, placebo-controlled study. JAMA Dermatol. 2013;149(9):1040–9.

    Article  CAS  Google Scholar 

  • Droicourt C, Rybojad M, Porcher R, Julliard C, Cosnes A, Joly P, Lacour J, D’Incan M, Dupin N, Sassolas B, Laurent M, Chevrant-Breton J, Lebrun-Vignes B, Dessaux K, Valeyre D, Revux J, Tazi A, Chosidow O, Dupuy A. A randomized, investigator-masked, double-blind, placebo-controlled trial on alidomide in severe cutaneous sarcoidosis. Chest. 2014;146(4):1046–54.

    Article  Google Scholar 

  • Haimovic A, Sanchez MD, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist. J Am Acad Dermaol. 2012;66(5):699.e1.

    Google Scholar 

  • Honari G. Clinical scoring of atopic dermatitis. In: Humbert P, et al., editors. Measuring the skin. Cham: Springer International Publishing; 2015.

    Google Scholar 

  • Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, Drent M. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomized trial. Eur Respir J. 2008;31:1189–96.

    Article  CAS  Google Scholar 

  • Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu F, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, Wijsenbeek MS, Albera C, Huizar I, Agarwal P, Brodmerkel C, Watt R, Barnathan ES. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur Respir J. 2014;44:1296–307.

    Article  CAS  Google Scholar 

  • Lacarrubba F, Pellacani G, Gurgone S, Verzi AE, Micali G. Advances in non-invasive techniques as aids to the diagnosis and monitoring of therapeutic response in plaque psoriasis: a review. Int J Dermatol. 2015;54:626–34.

    Article  Google Scholar 

  • Li Y, Berenji GR. Cutaneous sarcoidosis evaluated by FDG PET. Clin Nucl Med. 2011;36(7): 584–6.

    Article  Google Scholar 

  • Mlosek RK, Malinowska S. Ultrasound image of the skin, apparatus, and imaging basics. J Ultrason. 2013;13:212–21.

    Article  Google Scholar 

  • Noe MH, Rodriguez O, Taylor L, Schultz S, Gelfand JM, Judson MA, Rosenbach M. High frequency ultrasound: a novel measure of granuloma burden in cutaneous sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2018;34(2):136–141.

    Google Scholar 

  • Pariser RJ, Paul J, Hirano S, Torosky C, Smith M. A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. J Am Acad Dermatol. 2012;68(5):765–73.

    Article  Google Scholar 

  • Pascoe VL, Enamandram M, Corey KC, Cheng CE, Javorsky EJ, Sung SM, Donahue KR, Kimball AB. Using the physician global assessment in a clinical setting to measure and track patient outcomes. JAMA Dermatol. 2015;151(4):375–81.

    Article  Google Scholar 

  • Rosenbach M, Murrell DF, Bystryn J, Dulay S, Dick S, Farkharzadeh S, Hall R, Korman NJ, Lin J, Okawa J, Pandya AG, Payne AS, Rose M, Rubenstein D, Woodley D, Vittorio C, Werth BB, Williams EA, Taylor L, Troxel AB, Werth VP. Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol. 2009;129:2404–10.

    Article  CAS  Google Scholar 

  • Rosenbach M, Yeung H, Chu EY, Kim EJ, Payne AS, Takeshita J, Vittorio CC, Wanat KA, Werth VP, Gelfand JM. Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis. JAMA Dermatol. 2013;149(5): 550–6.

    Article  Google Scholar 

  • Stokkel MPM, van der Hiel B, Olmos RV, Hoefnagel K. Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma. Eur J Nucl Med Mol Imaging. 2012;39:919–20.

    Article  Google Scholar 

  • Wanat KA, Rosenbach M. Cutaneous sarcoidosis. Clin Chest Med. 2015;36:685–702.

    Article  Google Scholar 

  • Yeung H, Farber S, Birnbaum BK, Dunham J, Ogdie A, Patterson KC, Payne AS, Porteous MK, Rossman MD, Sharim R, Takeshita J, Werth VP, Shin DB, Price S, Rosenbach M. Reliability and validity of cutaneous sarcoidosis outcome instruments among dermatologists, pulmonologists, and rheumatologists. JAMA Dermatol. 2015;151(12):1317–1322.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William Fix .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Fix, W., Rosenbach, M. (2019). Cutaneous Sarcoidosis Outcome Instruments: Reliability and Validity Among Dermatologists, Pulmonologists, and Rheumatologists. In: Maibach, H., Osman, N. (eds) Cutaneous Biometrics. Springer, Cham. https://doi.org/10.1007/978-3-319-56591-0_31-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56591-0_31-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56591-0

  • Online ISBN: 978-3-319-56591-0

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics